Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Procomcure Biotech is an Austrian biotechnology company specializing in molecular biology and diagnostic solutions. Founded in 2013 and headquartered in Thalgau, the company focuses on the development and manufacturing of high-performance PCR-based diagnostic kits and reagents under its PhoenixDx brand. They provide a wide range of products for detecting infectious diseases, including SARS-CoV-2, influenza, and RSV, as well as specialized reagents like polymerases and master mixes for research. In addition to product manufacturing, Procomcure offers contract research services, assay development, and next-generation sequencing (NGS) to global partners. The company is ISO 13485 certified, ensuring its manufacturing processes meet international standards for medical device quality management. Procomcure played a critical role in large-scale diagnostic testing during the COVID-19 pandemic, particularly within the European market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Procomcure Biotech.